This article is more than 5 years old. Information may no longer be current.
Indo-American Cancer Association honors City of Hope researcher
The Indo-American Cancer Association honored Ravi Salgia, MD, PhD, with its IACA Award for Outstanding Contributions to Oncology.
Salgia, who serves as Arthur and Rosalie Kaplan endowed chair in medical oncology and associate director for clinical sciences at City of Hope’s comprehensive cancer center, also served as the keynote speaker at the association’s meeting in June.
Salgia’s 25 years in translational research have contributed to the development of targeted therapies that prolonged survival and improved quality of life for patients, particularly those with small cell lung cancer.
He was the first to clone the focal adhesion protein paxillin and also localize the gene to 12q24. His laboratory identified the gain-of-function mutations of paxillin in lung cancer, defined receptor tyrosine kinases and identified unique targets in lung cancer, such as MET/RON and EPHB4 receptor tyrosine kinases.
“It is an honor to receive this award from the IACA,” Salgia said in a press release. “City of Hope appreciates IACA’s recognition of the critical oncology research that is underway.”
The Indo-American Cancer Association, a 501(c)(3) organization, formed in 1993 to organize the large number of Indo-American physicians entering the field of oncology into a group that could serve as a cohesive agent for change. The organization supports programs related to cancer care and prevention, education and mentoring.